New Safety Signal: Dysesthesia The TRIUMPH-4 Phase 3 trial revealed a previously unreported side effect called dysesthesia, which is an abnormal sensation of touch where normal sensory input feels unusual or uncomfortable
Adults with obesity (BMI 30) or with overweight (BMI 27) plus at least one weight-related condition such as type 2 diabetes, hypertension or dyslipidaemia
Which medication is better for weight loss
Acrolein is used as a herbicide and algaecide, but it is also produced by the burning of fossil fuels, cigarette smoke, burning fats, and the oxidation of volatile organic compounds that are emitted in new construction
The short-chain fatty acid (SCFA) butyrate, which is produced by the microbial fermentation of dietary fiber in the large intestine, has been shown to have multiple beneficial effects in mammals 4,5,6,7,8,9